Like any form of radiotherapy, ionising radiation can harm healthy tissue as well as the intended treatment target. Radiation from lutetium (177Lu) oxodotreotide can cause damage when the medicine passes through tubules in the kidney. Arginine/lysine can be used to reduce renal radiation exposure during<unk>  with lutetium (177Lu) oxodotreotide.
Peptide receptor radionuclide therapy
Radionuclide therapy
Targeted therapy
Monoclonal antibody therapy
Fluoride therapy
Multisystemic therapy
Chemoimmunotherapy
Targeted alpha-particle therapy